Joseph P. Pellegrino JR - 19 Dec 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Chief Financial Officer, Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol: LMAT
Transactions as of: 19 Dec 2022
Transactions value $: -$18,871
Form type: 4
Filing time: 21 Dec 2022, 20:02:35 UTC
Previous filing: 13 Dec 2022
Next filing: 27 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Options Exercise	$0	+16	+0.19%	$0.00	8.34K	19 Dec 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	-$11.3K	-246	-2.95%	$45.74	8.09K	19 Dec 2022	Direct	F2
transaction	LMAT	Common Stock	Options Exercise	$0	+8	+0.1%	$0.00	8.1K	20 Dec 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	-$7.62K	-164	-2.02%	$46.46	7.94K	20 Dec 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-16	-34.85%	$0.00	29.9	19 Dec 2022	Common Stock	16		Direct	F4
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-8	-25.11%	$0.00	23.9	20 Dec 2022	Common Stock	8		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.